Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ejaculatory physiology and dysfunction.

V A Master1, P J Turek

  • 1Department of Urology, University of California San Francisco, San Francisco, California, USA.

The Urologic Clinics of North America
|June 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.

Bone marrow transplantation·2016
Same author

The need for epididymovasostomy at vasectomy reversal plateaus in older vasectomies: a study of 1229 cases.

Andrology·2013
Same author

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

The Journal of urology·2011
Same author

Prostate cancer treatment ascertained from several sources: analysis of disagreement and error.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.

Urology·2010
Same author

Paternity after directed collection of testicular sperm for in vitro fertilization after BMT for hematological malignancies.

Bone marrow transplantation·2010
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Ejaculatory dysfunction can stem from various diseases and is treatable through behavioral, mechanical, medical, and surgical methods. Ongoing research is exploring the molecular basis of ejaculation.

Area of Science:

  • Reproductive medicine
  • Urology
  • Molecular biology

Background:

  • The physiological process of ejaculation is well-documented.
  • Various pathological conditions can lead to ejaculatory dysfunction.
  • Current understanding is expanding to the molecular mechanisms involved.

Purpose of the Study:

  • To provide an overview of ejaculatory dysfunction.
  • To discuss current diagnostic and therapeutic approaches.
  • To highlight emerging research at the molecular level.

Main Methods:

  • Literature review of established knowledge on ejaculation.
  • Analysis of disease processes affecting ejaculation.
  • Summary of available treatment modalities (behavioral, mechanical, medical, surgical).

Related Experiment Videos

  • Inclusion of recent molecular-level research findings.
  • Main Results:

    • Ejaculatory dysfunction is a recognized clinical issue with diverse etiologies.
    • A range of treatment options are available for managing ejaculatory dysfunction.
    • Molecular investigations are beginning to uncover the intricate biological pathways of ejaculation.

    Conclusions:

    • Ejaculatory dysfunction is a manageable condition with established treatment strategies.
    • Further research into the molecular aspects of ejaculation promises novel therapeutic targets.
    • A comprehensive understanding spans from clinical presentation to molecular mechanisms.